Julia P Gregory insider trades

Open-market stock purchases and sales by Julia P Gregory, Director at Nurix Therapeutics, Inc, from SEC Form 4 filings since Sep 11, 2014.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +30%.

Recent trades

DateStockTradeValue
May 15, 2026NRIX Nurix Therapeutics, IncBought (not open market)—
Apr 28, 2026BHVN Biohaven LtdBought (not open market)—

Companies traded

  • NRIX Nurix Therapeutics, Inc: other filings, last May 15, 2026
  • BHVN Biohaven Ltd: 1 buy, 3 sales, last Apr 28, 2026
  • CFRX CONTRAFECT Corp: 1 buy, last Mar 2, 2015

Get free alerts when Julia P Gregory files a new trade →